FDA 483 - Rogelio Machuca, MD - December 23, 2025

An FDA inspection of The Machuca Foundation, Inc. in Las Vegas, NV, identified significant deficiencies in clinical trial conduct. Observations included failures to complete required tests, obtain updated informed consent from subjects, and ensure proper administration of investigational products. The inspection also found inadequate and inaccurate records for investigational drug disposition.